GLP-1 drugs to include new warning about rare eye condition causing sudden blindness, FDA says
The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and pills linked to a rare eye condition that can cause sudden blindness.
The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and pills linked to a rare eye condition that can cause sudden blindness.
What's Your Reaction?
